Fundamentals menu
| Year Ending Dec 2020 (Update) | Year Ending Dec 2019 (Restated) | Year Ending Dec 2018 (Restated) | Year Ending Dec 2017 (Update) | |
|---|---|---|---|---|
| Net Sales | 3,047.68 | 2,705.80 | 2,533.05 | 3,307.24 |
| Revenue | 3,047.68 | 2,705.80 | 2,533.05 | 3,307.24 |
| Total Revenue | 3,047.68 | 2,705.80 | 2,533.05 | 3,307.24 |
| Cost of Revenue | 810.20 | 599.61 | 501.15 | 651.01 |
| Cost of Revenue, Total | 810.20 | 599.61 | 501.15 | 651.01 |
| Gross Profit | 2,237.48 | 2,106.19 | 2,031.90 | 2,656.23 |
| Selling/General/Administrative Expense | 1,882.91 | 1,698.05 | 1,532.76 | 1,876.20 |
| Labor & Related Expense | 187.94 | 123.89 | 136.53 | 224.28 |
| Selling/General/Administrative Expenses, Total | 2,070.85 | 1,821.94 | 1,669.29 | 2,100.48 |
| Research & Development | 262.96 | 191.56 | 177.30 | 250.88 |
| Depreciation | 69.28 | 55.95 | 42.39 | 74.27 |
| Amortization of Intangibles, Operating | 109.38 | 83.87 | 107.08 | 42.14 |
| Depreciation/Amortization | 178.67 | 139.82 | 149.47 | 116.41 |
| Impairment-Assets Held for Use | 356.35 | 3.32 | 0.00 | 0.00 |
| Impairment-Assets Held for Sale | -- | -- | -- | 12.20 |
| Other Unusual Expense (Income) | -1.06 | 8.24 | -121.23 | -- |
| Unusual Expense (Income) | 355.29 | 11.56 | -121.23 | 12.20 |
| Total Operating Expense | 3,677.97 | 2,764.49 | 2,375.98 | 3,130.97 |
| Operating Income | -630.29 | -58.69 | 157.07 | 176.27 |
| Interest Expense - Non-Operating | -16.17 | -11.90 | -13.06 | -105.30 |
| Interest Expense, Net Non-Operating | -16.17 | -11.90 | -13.06 | -105.30 |
| Interest Income, Non-Operating | 7.19 | 15.16 | 9.13 | 11.40 |
| Investment Income, Non-Operating | 851.21 | 22.81 | 27.37 | 51.70 |
| Interest/Investment Income, Non-Operating | 858.40 | 37.98 | 36.49 | 63.10 |
| Interest Income (Expense), Net-Non-Operating, Total | 842.23 | 26.07 | 23.43 | -42.20 |
| Gain (Loss) on Sale of Assets | -- | -- | -- | -- |
| Other Non-Operating Income (Expense) | -2.38 | 4.31 | 125.07 | -67.11 |
| Other, Net | -2.38 | 4.31 | 125.07 | -67.11 |
| Net Income Before Taxes | 209.57 | -28.31 | 305.57 | 66.96 |
| Income Tax – Total | -59.02 | -60.49 | 13.20 | -353.75 |
| Income After Tax | 268.59 | 32.18 | 292.37 | 420.71 |
| Minority Interest | 1.14 | -9.29 | -45.60 | -53.08 |
| Net Income Before Extraordinary Items | 269.73 | 22.90 | 246.77 | 367.62 |
| Discontinued Operations | -- | -- | -- | -- |
| Extraordinary Item | -- | -- | -- | -62.70 |
| Total Extraordinary Items | -- | -- | -- | -62.70 |
| Net Income | 269.73 | 22.90 | 246.77 | 304.92 |
| Income Available to Common Excluding Extraordinary Items | 269.73 | 22.90 | 246.77 | 367.62 |
| Income Available to Common Stocks Including Extraordinary Items | 269.73 | 22.90 | 246.77 | 304.92 |
| Basic Weighted Average Shares | 85.36 | 85.13 | 85.09 | 80.09 |
| Basic EPS Excluding Extraordinary Items | 3.16 | 0.27 | 2.90 | 4.59 |
| Basic EPS Including Extraordinary Items | 3.16 | 0.27 | 2.90 | 3.81 |
| Dilution Adjustment | -- | -- | -- | -- |
| Diluted Net Income | 269.73 | 22.90 | 246.77 | 304.92 |
| Diluted Weighted Average Shares | 85.36 | 85.13 | 85.09 | 85.31 |
| Diluted EPS Excluding Extraordinary Items | 3.16 | 0.27 | 2.90 | 4.31 |
| Diluted EPS Including Extraordinary Items | 3.16 | 0.27 | 2.90 | 3.57 |
| DPS - Common Stock Primary Issue | -- | -- | -- | -- |
| Dividend per Share – Common Stock Issue 2 | -- | -- | -- | -- |
| Gross Dividends - Common Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Unusual Expense (Income), Supplemental | -6.92 | 19.74 | -- | -- |
| Non-Recurring Items, Total | -6.92 | 19.74 | -- | -- |
| Total Special Items | 348.37 | 31.30 | -121.23 | 12.20 |
| Normalized Income Before Taxes | 557.94 | 2.99 | 184.34 | 79.16 |
| Effect of Special Items on Income Taxes | 121.93 | 10.95 | -5.24 | 4.27 |
| Income Taxes Excluding Impact of Special Items | 62.91 | -49.54 | 7.96 | -349.48 |
| Normalized Income After Taxes | 495.03 | 52.52 | 176.38 | 428.64 |
| Normalized Income Available to Common | 496.17 | 43.24 | 130.78 | 375.55 |
| Basic Normalized EPS | 5.81 | 0.51 | 1.54 | 4.69 |
| Diluted Normalized EPS | 5.81 | 0.51 | 1.54 | 4.40 |
| Amortization of Intangibles, Supplemental | 109.38 | 83.87 | 107.08 | 42.14 |
| Depreciation, Supplemental | 69.28 | 55.95 | 42.39 | 74.27 |
| Interest Expense, Supplemental | 16.17 | 11.90 | 13.06 | 105.30 |
| Rental Expense, Supplemental | 52.90 | 38.19 | -- | 37.90 |
| Stock-Based Compensation, Supplemental | 197.22 | 134.34 | 148.41 | 264.62 |
| Advertising Expense, Supplemental | 862.20 | 855.20 | 798.10 | 1,100.00 |
| Equity in Affiliates, Supplemental | -- | -- | -- | -- |
| Minority Interest, Supplemental | 1.14 | -9.29 | -45.60 | -53.08 |
| Research & Development Expense, Supplemental | 262.96 | 191.56 | 177.30 | 250.88 |
| Audit-Related Fees, Supplemental | -- | -- | -- | 2.80 |
| Audit-Related Fees | -- | -- | -- | 0.05 |
| Tax Fees, Supplemental | -- | -- | -- | 0.01 |
| All Other Fees Paid to Auditor, Supplemental | -- | -- | -- | -- |
| Gross Margin | 73.42 | 77.84 | 80.22 | 80.32 |
| Operating Margin | -20.68 | -2.17 | 6.20 | 5.33 |
| Pretax Margin | 6.88 | -1.05 | 12.06 | 2.02 |
| Effective Tax Rate | -28.16 | -- | 4.32 | -528.32 |
| Net Profit Margin | 8.85 | 0.85 | 9.74 | 11.12 |
| Normalized EBIT | -281.92 | -27.39 | 35.84 | 188.47 |
| Normalized EBITDA | -103.25 | 112.42 | 185.31 | 304.87 |
| Current Tax - Domestic | -29.18 | -1.12 | -1.19 | -95.64 |
| Current Tax - Foreign | -0.18 | 3.20 | 4.11 | 24.11 |
| Current Tax - Local | 2.25 | 0.20 | 1.51 | 1.96 |
| Current Tax - Total | -27.10 | 2.28 | 4.44 | -69.57 |
| Deferred Tax - Domestic | -20.05 | -51.95 | 20.16 | -254.38 |
| Deferred Tax - Foreign | -4.14 | -0.17 | -4.12 | -1.44 |
| Deferred Tax - Local | -7.73 | -10.65 | -7.27 | -28.36 |
| Deferred Tax - Total | -31.92 | -62.77 | 8.77 | -284.18 |
| Income Tax - Total | -59.02 | -60.49 | 13.20 | -353.75 |
| Defined Contribution Expense - Domestic | 20.50 | -- | -- | 11.10 |
| Defined Contribution Expense - Foreign | 1.00 | -- | -- | 2.50 |
| Total Pension Expense | 21.50 | -- | -- | 13.60 |
In millions of USD (except for per share items)
Copyright Refinitiv